83706-53-0 Usage
Uses
Used in Pharmaceutical Industry:
4-chloro-6-iodo-3-nitrotoluene is used as a key intermediate in the synthesis of various pharmaceuticals. Its unique structure allows for the development of new drugs with specific therapeutic properties. It plays a crucial role in the production of medications for treating a wide range of diseases and conditions.
Used in Agrochemical Industry:
In the agrochemical industry, 4-chloro-6-iodo-3-nitrotoluene is utilized as an intermediate for the synthesis of various agrochemicals. Its properties make it suitable for the development of pesticides, herbicides, and other agricultural chemicals that help protect crops and enhance agricultural productivity.
Used in Dye and Pigment Production:
4-chloro-6-iodo-3-nitrotoluene is also used in the production of specific dyes and pigments. Its unique chemical structure contributes to the development of dyes with distinct color properties, making it valuable in various applications such as textiles, plastics, and printing inks.
Used in Organic Compound Synthesis:
Due to its versatile chemical properties, 4-chloro-6-iodo-3-nitrotoluene is employed as an intermediate in the synthesis of other organic compounds. It serves as a building block for the creation of various chemical entities with potential applications in different industries, including materials science, chemical research, and specialty chemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 83706-53-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,3,7,0 and 6 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 83706-53:
(7*8)+(6*3)+(5*7)+(4*0)+(3*6)+(2*5)+(1*3)=140
140 % 10 = 0
So 83706-53-0 is a valid CAS Registry Number.
InChI:InChI=1/C7H5ClINO2/c1-4-2-7(10(11)12)5(8)3-6(4)9/h2-3H,1H3
83706-53-0Relevant academic research and scientific papers
IRAK DEGRADERS AND USES THEREOF
-
Paragraph 00920; 003492-003494, (2021/01/23)
The present invention provides compounds, compositions thereof, and methods of using the same. The compounds include an IRAK binding moiety capable of binding to IRAK4 and a degradation inducing moiety (DIM). The DIM could be DTM a ligase binding moiety (LBM) or lysine mimetic. The compounds could be useful as IRAK protein kinase inhibitors and applied to IRAK mediated disorders.
INHIBITORS OF VIRAL REPLICATION
-
Page/Page column 54, (2009/04/24)
The embodiments provide compounds of the general Formulas I-IV, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.
ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF
-
Page/Page column 157-158, (2010/02/10)
Compounds that are VLA-1 integrin antagonists are disclosed. Also disclosed are compositions containing such compounds, and methods of using such compounds in treating diseases mediated, at least in part, by the VLA-1 integrin.
